Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer
Jonathan Kluger, Alicia Roy, Herta H. Chao
Current Oncology Reports (2020) Vol. 22, Iss. 3
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

A Comprehensive Review and Androgen Deprivation Therapy and Its Impact on Alzheimer’s Disease Risk in Older Men with Prostate Cancer
Manisha Singh, Vinayak Agarwal, Pranav Pancham, et al.
Degenerative Neurological and Neuromuscular Disease (2024) Vol. Volume 14, pp. 33-46
Open Access | Times Cited: 25
Green Metallic Nanoparticles for Cancer Therapy: Evaluation Models and Cancer Applications
Ernesto Tinajero‐Díaz, Daniela Salado‐Leza, Carmen González, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1719-1719
Open Access | Times Cited: 49
The loss of estradiol by androgen deprivation in prostate cancer patients shows the importance of estrogens in males
Herjan J.T. Coelingh Bennink, Amanda Prowse, Jan F M Egberts, et al.
Journal of the Endocrine Society (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 5
Androgen deprivation therapy and dementia risk: An updated and dose-response meta-analysis
Shun Zhu, Jingnian Ni, Siwei Long, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function
Allison B. Reiss, Usman Saeedullah, David Grossfeld, et al.
Clinical & Translational Oncology (2021) Vol. 24, Iss. 5, pp. 733-741
Closed Access | Times Cited: 19
Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer
Andreas Ihrig, Pascal Marino Pernt, Stefanie Zschäbitz, et al.
International Urology and Nephrology (2023) Vol. 55, Iss. 11, pp. 2733-2739
Open Access | Times Cited: 7
The Clinical, Diagnostic, Therapeutic, and Prognostic Characteristics of Brain Metastases in Prostate Cancer: A Systematic Review
Seyyedmohammadsadeq Mirmoeeni, Amirhossein Azari Jafari, Muffaqam Shah, et al.
Prostate Cancer (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 12
Hypothalamic connectivities predict individual differences in ADT-elicited changes in working memory and quality of life in prostate cancer patients
Shefali Chaudhary, Alicia Roy, Christine Summers, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Analysis of Brain Functions in Men with Prostate Cancer under Androgen Deprivation Therapy: A One-Year Longitudinal Study
Vanessa Sánchez‐Martínez, Cristina Buigues, Rut Navarro-Martínez, et al.
Life (2021) Vol. 11, Iss. 3, pp. 227-227
Open Access | Times Cited: 14
Androgen deprivation therapy and cognitive decline—associations with brain connectomes, endocrine status, and risk genotypes
Cecilie R. Buskbjerg, Ali Amidi, Simon Buus, et al.
Prostate Cancer and Prostatic Diseases (2021) Vol. 25, Iss. 2, pp. 208-218
Closed Access | Times Cited: 14
DHT inhibits REDOX damage and neuroinflammation to reduce PND occurrence in aged mice via mmu_circ_0001442/miR‐125a‐3p/NUFIP2 axis
Liu Li, Liwen Liu, Daying Zhang, et al.
Brain and Behavior (2023) Vol. 13, Iss. 10
Open Access | Times Cited: 4
Online Group Cognitive Rehabilitation Program for Prostate Cancer Survivors: Development Using Codesign and the Theoretical Domains Framework
Lorna Pembroke, Kerry A. Sherman, Haryana M. Dhillon, et al.
Seminars in Oncology Nursing (2024) Vol. 40, Iss. 5, pp. 151695-151695
Open Access | Times Cited: 1
Effect of estradiol on cognition in men undergoing androgen deprivation therapy: A randomized placebo‐controlled trial
Nicholas Russell, James Allebone, Orwa Dandash, et al.
Clinical Endocrinology (2022) Vol. 97, Iss. 5, pp. 622-633
Closed Access | Times Cited: 7
How Does Androgen Deprivation Therapy Affect Mental Health including Cognitive Dysfunction in Patients with Prostate Cancer?
Hyung Ho Lee, Sahyun Park, Jae Young Joung, et al.
The World Journal of Men s Health (2020) Vol. 39, Iss. 4, pp. 598-598
Open Access | Times Cited: 10
Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link?
Myungsun Shim, Woo Jin Bang, Cheol Young Oh, et al.
Prostate International (2021) Vol. 10, Iss. 1, pp. 68-74
Open Access | Times Cited: 9
Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer
Gregory L. Branigan, Georgina Torrandell‐Haro, Maira Soto, et al.
Cancer Medicine (2022) Vol. 11, Iss. 13, pp. 2687-2698
Open Access | Times Cited: 6
Vortioxetine in management of major depressive disorder – a favorable alternative for elderly patients?
Dorota Danielak
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 9, pp. 1167-1177
Closed Access | Times Cited: 8
Proteomics reveals the function reverse of MPSSS‐treated prostate cancer‐associated fibroblasts to suppress PC‐3 cell viability via the FoxO pathway
Tingting Zhang, Xiulan Chen, Lang Sun, et al.
Cancer Medicine (2021) Vol. 10, Iss. 7, pp. 2509-2522
Open Access | Times Cited: 7
Behavior is movement only but how to interpret it? Problems and pitfalls in translational neuroscience—a 40-year experience
Hans‐Peter Lipp, David P Wolfer
Frontiers in Behavioral Neuroscience (2022) Vol. 16
Open Access | Times Cited: 5
Cognitive decline in patients with prostate cancer: study protocol of a prospective cohort, NEON-PC
Natália Araújo, Samantha Morais, Ana Rute Costa, et al.
BMJ Open (2021) Vol. 11, Iss. 2, pp. e043844-e043844
Open Access | Times Cited: 6
Cognitive Dysfunction in Patients Treated with Androgen Deprivation Therapy: A Multimodality Functional Imaging Study to Evaluate Neuroinflammation
Azeem Saleem, Syed Imran Ali Shah, Stephen Mangar, et al.
Prostate Cancer (2023) Vol. 2023, pp. 1-12
Open Access | Times Cited: 2
Treatment-Related Cognitive Impairment in Patients with Prostate Cancer: Patients’ Real-World Insights for Optimizing Outcomes
Bruce Cowan, Kara Olivier, Bertrand Tombal, et al.
Advances in Therapy (2023) Vol. 41, Iss. 2, pp. 476-491
Open Access | Times Cited: 2
The effect of estradiol add-back: a longitudinal MRI study in prostate cancer patients
Orwa Dandash, James Allebone, Adam G. Mirabelli, et al.
Endocrine Connections (2024) Vol. 13, Iss. 3
Open Access
Cognitive effects of long‐term androgen deprivation therapy in older men with prostate cancer
Denise Pergolizzi, Kathleen R. Flaherty, Rebecca M. Saracino, et al.
Psycho-Oncology (2024) Vol. 33, Iss. 3
Closed Access
Psychosocial Factors Associated with Cognitive Function in Prostate Cancer Survivors on Hormonal Treatments: A Systematic Review
Lorna Pembroke, Kerry A. Sherman, Heather Francis, et al.
Neuropsychology Review (2024)
Open Access
Page 1 - Next Page

Scroll to top